Cole Pinnow - 25 May 2024 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Commercial Officer
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
25 May 2024
Net transactions value
$0
Form type
4
Filing time
29 May 2024, 16:03:03 UTC
Next filing
15 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +525,000 $0.000000 525,000 25 May 2024 Common Stock 525,000 $8.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of May 25, 2024, with the remainder vesting in equal monthly installments through May 25, 2028, subject to the Reporting Person's continued service to the Issuer.